Share the news WhatsApp Facebook X LinkedIn CRO Solutions and it’s sisters company, the Medicines Evaluation Unit, have recently partnered with Arxx Therapeutics. We happy to share that, with the [ … ]
Category: Uncategorised
Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients
Share the news WhatsApp Facebook X LinkedIn Two-part Phase 1b trial will evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profile of inhaled pan-JAK inhibitor KN-002 Study is being conducted at [ … ]
FIRST PATIENT DOSED IN PHASE 2 STUDY FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH ACUTE LUNG INJURY CAUSED BY COVID-19
Share the news WhatsApp Facebook X LinkedIn The initiation of the Phase 2 study in patients in the United Kingdom (UK) follows the successful completion of dosing in the Phase 1 study [ … ]